Elevation Oncology Inc. (ELEV)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on May 16, 2024, 7:00 pm based on SEC 13F filings Last update: May 16, 2024, 7:00 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Farallon Capital Thomas Steyer	3,886,663	$19,938,581		0.09%
2.	Point72 Asset Management Steve Cohen	3,368,200	$17,278,866		0.04%
3.	Tang Capital Management Kevin C. Tang	3,060,000	$15,697,800	-17%	1.63%
4.	Balyasny Asset Management Dmitry Balyasny	3,055,479	$15,674,607		0.02%
5.	Braidwell LP Alex Karnal	2,377,647	$12,197,329		0.39%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Qiming	$16.00	312,500	Large Shareholder	2,370,142	2021-06-29	Filing
Aisling	$16.00	187,500	Large Shareholder	2,834,910	2021-06-29	Filing
Vertex	$16.00	250,000	Large Shareholder	2,307,642	2021-06-29	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Venbio	$4.12	702,737		1,905,430	2022-05-25	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Venbio Partners Llc	2,914,255	$1,564,955	0.23%
2.	Aisling Capital Management Lp	2,834,910	$1,522,347	0.45%
3.	Qiming U.s. Ventures Management, Llc	2,370,142	$1,272,766	1.16%
4.	Vanguard Group Inc	1,171,246	$628,959	0%
5.	Two Sigma Investments, Lp	364,892	$195,947	0%